HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

The HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice funding opportunity is administered by the National Institutes of Health within the U.S. Department of Health and Human Services. This program is part of the Helping to End Addiction Long-term (HEAL) Initiative, a federal effort designed to address the opioid crisis and reduce overdose-related mortality through coordinated scientific research. The funding opportunity focuses on advancing applied research that bridges the gap between scientific discovery and real-world implementation, particularly in addiction prevention, treatment, and recovery systems. The primary purpose of this grant is to support action-oriented research that accelerates the translation of evidence-based interventions into routine practice. The program emphasizes scalable and replicable solutions that can be implemented across various settings, including healthcare systems, public health agencies, and community organizations. Projects may address addiction and substance use disorders broadly, with particular attention to opioid use and overdose prevention. Research may also explore the intersection of substance use disorders with chronic pain, reflecting the complexity of patient needs in real-world environments. Funding supports a wide range of research activities, including the identification of modifiable risk and protective factors, development and testing of interventions, and evaluation of implementation strategies. Applicants may propose studies at multiple levels, such as individual, provider, organizational, or system-wide approaches. The funding mechanism follows the R61/R33 phased innovation model, which allows for an initial exploratory phase followed by a larger implementation phase contingent on achieving predefined milestones. This structure encourages both innovation and accountability in project development. Eligibility for this opportunity is broad and includes public and private institutions of higher education, nonprofit organizations with and without 501(c)(3) status, state and local governments, tribal governments and organizations, school districts, small businesses, and for-profit entities. However, non-U.S. organizations and foreign components of U.S. organizations are not eligible to apply, although certain foreign collaborations may be permitted under NIH policy. Applicants are expected to meet all requirements outlined in the full notice of funding opportunity, including compliance with NIH research standards and policies. The application process requires submission through standard federal grant systems, including Grants.gov. Applicants must prepare detailed research proposals outlining study design, implementation strategies, evaluation methods, and anticipated impact. Applications are evaluated based on scientific merit, feasibility, innovation, and potential for real-world impact. Peer review processes follow NIH guidelines, and funding decisions are made based on review scores and programmatic priorities. The funding opportunity was posted on June 4, 2026, and applications are accepted until February 9, 2029. There is no cost-sharing or matching requirement associated with this program. While specific award amounts and the number of awards are not listed in the summary, applicants should consult the full announcement for detailed budget guidance and project period expectations. This opportunity represents a significant federal investment in translating addiction research into practice and improving public health outcomes nationwide.